More than ten years have gone into R&D and now Plandaí Biotechnology, Inc. (PLPL), a producer of highly bioavailable Phytofare™ plant extracts, is geared up for commercialization.
The company is announcing 3 exclusive commodities into the $29-billion U.S. nutritional supplements business and $50-billion global tea market. Vitamin Shoppe (VSI) approximates that 150 million individuals in the USA consume a dietary supplement each day. Plandaí’s products should instantly interest this massive audience. This will give Plandaí Biotechnology, Inc. (P L P L) a competitive edge and should springboard the company onto the scene.
The use of research materials created by the author is done at your own risk. You are encouraged to do your own research before making any investment decision in regards to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the distribution of these materials. You should presume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (collectively referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with PLPL, the author has taken a long position. Following the distribution of any report or letter, the author intends to continue engaging in trnsactns in the security covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report.
30 S. Wacker Dr., 22nd Fl., Chicago, Ill.IL 60606 U.S.A.